Courouce AM - Search Results

1

Letter: Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.

Delons S, Kleinknecht D, Courouce AM. Delons S, et al. Among authors: courouce am. Lancet. 1976 Jan 24;1(7952):204-5. doi: 10.1016/s0140-6736(76)91322-2. Lancet. 1976. PMID: 54725 Clinical Trial. No abstract available.

2

Anti-HBs immune globulin to prevent hepatitis B.

Couroucé AM, Naret C, Ciancionni C, Delons S. Couroucé AM, et al. Lancet. 1978 Mar 4;1(8062):504. doi: 10.1016/s0140-6736(78)90168-x. Lancet. 1978. PMID: 76050 No abstract available.

3

Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. A controlled study.

Kleinknecht D, Courouce AM, Delons S, Naret C, Adhemar JP, Ciancioni C, Fermanian J. Kleinknecht D, et al. Among authors: courouce am. Clin Nephrol. 1977 Sep;8(3):373-6. Clin Nephrol. 1977. PMID: 912951 Clinical Trial.

4

An attempt to prevent hepatitis B in a haemodialysis unit's team utilisation of specific immunoglobulins.

Delons S, Naret C, Ciancioni C, Courouce AM, Soulier JP. Delons S, et al. Among authors: courouce am. Proc Eur Dial Transplant Assoc. 1975;11:237-43. Proc Eur Dial Transplant Assoc. 1975. PMID: 1197259

5

[Hepatitis C virus infection at a hemodialysis unit in Paris].

Couroucé AM, Chauveau P, Le Marrec N, Naret C, Delons S. Couroucé AM, et al. Presse Med. 1991 Apr 6;20(13):609. Presse Med. 1991. PMID: 1827909 French. No abstract available.

6

Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.

Chauveau P, Courouce AM, Lemarec N, Naret C, Poignet JL, Girault A, Ramdame M, Delons S. Chauveau P, et al. Among authors: courouce am. Kidney Int Suppl. 1993 Jun;41:S149-52. Kidney Int Suppl. 1993. PMID: 7686591

7

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.

Crosnier J, Jungers P, Couroucé AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P. Crosnier J, et al. Among authors: courouce am. Lancet. 1981 Apr 11;1(8224):797-800. doi: 10.1016/s0140-6736(81)92679-9. Lancet. 1981. PMID: 6111671 Clinical Trial.

8

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff.

Crosnier J, Jungers P, Couroucé AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P. Crosnier J, et al. Among authors: courouce am. Lancet. 1981 Feb 28;1(8218):455-9. doi: 10.1016/s0140-6736(81)91847-x. Lancet. 1981. PMID: 6110088 Clinical Trial.

9

Responses to hepatitis B vaccine.

Laplanche A, Courouce AM, Benhamou E, Jungers P, Crosnier J. Laplanche A, et al. Among authors: courouce am. Lancet. 1982 Jan 23;1(8265):222. doi: 10.1016/s0140-6736(82)90784-x. Lancet. 1982. PMID: 6119578 No abstract available.

10

Timing of hepatitis B revaccination in healthy adults.

Laplanche A, Courouce AM, Benhamou E, Jungers P. Laplanche A, et al. Among authors: courouce am. Lancet. 1987 May 23;1(8543):1206-7. doi: 10.1016/s0140-6736(87)92176-3. Lancet. 1987. PMID: 2883518 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters